Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases
Opioid use is associated with excess mortality in patients with inflammatory bowel disease (IBD) It is unknown if preadmission use of cannabis increases the risk for inpatient opioid exposure. Cannabis is commonly used for symptom relief among patients with IBD. A personalized pain management approach should be considered to limit inpatient exposure and possibly future opioid exposure among hospitalized patients with IBD who use cannabis.
